• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

Varied Presentations of Tinea Versicolor: Case 2 Truncal Tinea Versicolor

Article

Large, reddish tan, asymptomatic patches recently developedon the trunk of a 36-year-old man. Five years earlier,a similar outbreak had resolved after a 10-day course oforal ketoconazole; this episode was the first recurrence.

Large, reddish tan, asymptomatic patches recently developedon the trunk of a 36-year-old man. Five years earlier,a similar outbreak had resolved after a 10-day course oforal ketoconazole; this episode was the first recurrence.Tinea versicolor is a superficial skin infection causedby Pityrosporum orbiculare and Pityrosporum ovale, alsoknown as Malassezia furfur. The diagnosis is easily madeby the clinical appearance and can be confirmed by a potassiumhydroxide preparation that shows hyphae--short,rod-shaped fragments intermixed with round spores andgrapelike clusters--in what is referred to as the "spaghettiand meatballs" pattern. Recurrences are common andoccur most often in the spring and summer.Topical treatments include selenium sulfide suspension2.5%, sodium thiosulfate 25%, ketoconazole, miconazole,clotrimazole, econazole, ciclopirox, sulfosalicylicacid shampoo, and zinc pyrithione shampoo. Oral therapiesinclude ketoconazole, itraconazole, and fluconazole.Griseofulvin is ineffective.A 10-day course of oral ketoconazole was prescribedbecause of its previous effectiveness in this patient.

(Case and photographs courtesy of Dr Robert P. Blereau.)

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
© 2025 MJH Life Sciences

All rights reserved.